Posts Tagged ‘biotech manufacturing’

Capital Project Efficiency-Operational Flexibility-Product Lifecycle Efficiency at Interphex

Posted in Event, Life Sciences on Tuesday, March 14th, 2017. No comments yet
Tags: , , ,

Author: Michalle Adkins At the March 21-23 Interphex 2017, Emerson exhibitor staff will be discussing three main themes: delivering capital projects on time with lower risk; comprehensive automation solutions for flexible, single-use facilities; and improving efficiency across the product lifecycle. Life Sciences companies are expanding globally in order to provide life-saving or life-enhancing solutions to […]

Best Practices Specifying MES Workflows for Life Sciences Projects

Posted in Life Sciences, Operations Management on Thursday, January 26th, 2017. No comments yet
Tags: , , , , , ,

Author: Jonathan Lustri Manufacturing Execution System (MES) Life Sciences projects can be costly and be a challenge to keep in control. The biggest contributor to these challenges are the defining and design of manufacturing workflows. A Workflow is an MES procedural object used to replace the paper batch record. And for greenfield projects in particular, […]

Measurement Repeatability in CIP and SIP Operations

Posted in Life Sciences, Pressure on Tuesday, January 10th, 2017. No comments yet
Tags: , , , ,

One only has to do a Google image search on pharmaceutical equipment to see the clean, sanitary conditions required for pharmaceutical and biopharmaceutical processing. The measurement instrumentation must be able to handle the tough conditions when cleaning and sanitization operations are performed. In a Pharmaceutical Manufacturing article, Ensuring Batch-to-Batch Repeatability in Sanitary Processes, Emerson’s Kyle […]

Pharmaceutical and Biotech Manufacturing Data Integrity

Posted in Life Sciences on Thursday, November 10th, 2016. No comments yet
Tags: , , , , ,

The integrity of the data behind the production of pharmaceutical products is paramount. In recent years, the U.S. Food & Drug Administration (FDA) has increasingly observed data integrity related Current Good Manufacturing Practices (CGMP) violations during CGMP inspections. At the recent Emerson Exchange conference, Emerson’s Michalle Adkins co-moderated the Life Sciences Industry Forum session with […]

Pharmaceutical and Biotech Automation Knowledge Exchange

Posted in Emerson Exchange, Event, Life Sciences on Thursday, October 13th, 2016. No comments yet
Tags: , , , , ,

The pharmaceutical and biopharmaceutical industries have been interpreting recent FDA draft guidance—Data Integrity and Compliance With CGMP Guidance—and exploring new areas such as continuous manufacturing. The Emerson Life Sciences team has a full program of forums, workshops and short courses available for manufacturers in the Life Sciences industries at to October 24-28 Emerson Exchange conference […]